Contact Us

BUSINESS NEWS

XellSmart's Allogeneic iPSC-derived Cell Therapies for Parkinson's Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials

Apr 17, 2025

SUZHOU,China,April 15,2025-- In January 2025 (U.S. time),the U.S. Food and Drug Administration (FDA) officially approved the Investigational New Drug (IND) application submitted by XellSmart Biopharma

OutSystems Announces ONE 2025: The Future of AI-Powered Application and Agent Development Unveiled

Apr 17, 2025

The annual event returns to Lisbon with Diego LoGiudice,software transformation expert and Research VP,Principal Analyst,announced as a lead speaker

GTN and Webull Singapore open up fixed income investing to APAC investors

Apr 17, 2025

SINGAPORE,April 16,2025-- GTN,a global fintech redefining trading and investing for all,today announced its partnership with Webull Singapore ("Webull"),a leading global investment platform

The Lancet Child & Adolescent Health Publishes Phase III Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months

Apr 17, 2025

SHANGHAI,April 16,2025-- The Lancet Child & Adolescent Health,a leading international journal in pediatric and adolescent medicine,has published the Phase III clinical trial results of ziresovir,

Indonesia in Focus as FancyTech's B+ Funding Drives Global AI Content Growth

Apr 17, 2025

JAKARTA,Indonesia,April 16,2025-- FancyTech,the Grand Winner of the 2024 LVMH Innovation Award and an AI startup specializing in commercial content generation,has successfully closed its Series B+ fun

The 8th China EdFest Gives Parents a Powerful Voice

Apr 17, 2025

SHANGHAI,April 16,2025--The 8th China Festival of Education,hosted by Wellington College China,brought togetherover 70 speakersandmore than 800 attendeesfrom around the world. Held on Saturday 12 Apri

1 ... 14 15 16 17 18 19 20 ... 348